Dr. Jiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Lahey Hospital and Medical Center
Department of Radiation Oncology
Burlington, MA 01805
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2015 - 2019
- Washington University in St. Louis School of MedicineClass of 2015
- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year
Certifications & Licensure
- MA State Medical License 2020 - 2026
- NH State Medical License 2020 - 2026
- CA State Medical License 2016 - 2020
- MO State Medical License 2015 - 2016
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 33 citationsStereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.Ritchell van Dams, Naomi Y. Jiang, Donald B. Fuller, Andrew Loblaw, Tommy Jiang
International Journal of Radiation Oncology, Biology, Physics. 2021-01-23 - 21 citationsDose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.Rebecca Levin-Epstein, Naomi Y. Jiang, Xiaoyan Wang, Shrinivasa K. Upadhyaya, Sean P. Collins
Radiotherapy and Oncology. 2021-01-01 - 18 citationsProstate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy...Rebecca Levin-Epstein, Ryan Cook, J. Karen Wong, Richard G. Stock, D. Jeffrey Demanes
Radiotherapy and Oncology. 2020-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: